Dataiku Raises $100 Million To Extend Leadership In Enterprise AI Market

News

The French Unicorn, with Alven since its inception, continues its impressive growth with its latest funding round

Dataiku, one of the world’s leading Enterprise AI and machine learning platforms, announced a $100 million Series D investment round led by Stripes, and Tiger Global Management joins existing investors CapitalG, Dawn Capital, ICONIQ, Battery Ventures and FirstMark Capital.

The funding comes as Dataiku continues to drive AI within the enterprise, serving 300 customers who understand that a collaborative and end-to-end AI strategy is critical to their success.

“Our leadership in enterprise AI continues to attract world-class investors who understand that Dataiku’s solution and customer base are truly global and that we’re uniquely positioned to help businesses realize the untapped potential for AI to transform the enterprise,” said Florian Douetteau, co-founder and CEO of Dataiku. “In a global business market rocked by the changes 2020 has brought, AI has proven to be a critical element of organizational success driving business growth in every major vertical market.”

Dataiku was founded in 2013 with the mission to take machine learning and AI projects out of experimental labs and put it into everyday operations that are truly woven into the fabric of a company. 

Dataiku serves hundreds of customers worldwide, including Schlumberger, GE Aviation, Sephora, Unilever, BNP Paribas, Premera Blue Cross, Kuka, and Santander. Its team has grown to more than 450 people worldwide in New York, Paris, London, Frankfürt, Dubai, Amsterdam, Sydney, and Singapore.


Share

Skarlett Raises €8 Million Seed Round to Reinvent Personal Finance for the 60+ Generation

Skarlett, the marketplace dedicated to the financial needs of those over 60, today announces an €8 million seed funding round. The round…

Read

Carbon credits, built for business: Riverse €5M seed round

Riverse raised €5 million in seed funding to make carbon credits work for real companies and the real challenges they face. Alven…

Read

Okeiro raises €10 Million to accelerate development of its Precision Medicine platform for Transplantation and Chronic Diseases

Okeiro, a company specializing in precision medicine for transplantation and advanced chronic diseases, today announces a €10 million funding round to accelerate…

Read